The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
CCR3 is a target for age-related macular degeneration diagnosis and therapy
Open accessAbstract
Age-related macular degeneration (AMD), a leading cause of blindness worldwide, is as prevalent as cancer in industrialized nations. Most blindness in AMD results from invasion of the retina by choroidal neovascularisation (CNV). Here we show that the eosinophil/mast cell chemokine receptor CCR3 is specifically expressed in choroidal neovascular endothelial cells in humans with AMD, and that despite the expression of its ligands eotaxin-1, -2 and -3, neither eosinophils nor mast cells are present in human CNV. Genetic or pharmacological targeting of CCR3 or eotaxins inhibited injury-induced CNV in mice. CNV suppression by CCR3 blockade was due to direct inhibition of endothelial cell proliferation, and was uncoupled from inflammation because it occurred in mice lacking eosinophils or mast cells, and was independent of macrophage and neutrophil recruitment. CCR3 blockade was more effective at reducing CNV than vascular endothelial growth factor A (VEGF-A) neutralization, which is in clinical use at present, and, unlike VEGF-A blockade, is not toxic to the mouse retina. In vivo imaging with CCR3-targeting quantum dots located spontaneous CNV invisible to standard fluorescein angiography in mice before retinal invasion. CCR3 targeting might reduce vision loss due to AMD through early detection and therapeutic angioinhibition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Elevated CCL11 in the plasma and cerebrospinal fluid seen in aging mice and humans are associated with declining neurogenesis, neurodegenerative disease, and cognitive decline and may contribute to driving neovascularisation in AMD via interaction with CCR3 [1, 93, 123].”
From Fecal microbiota transfer between young and aged mice reverses hallmarks of the aging gut, eye, and brain (2022) · cites this paper as [1]
In the citing paper
“Elevated CCL11 in the plasma and cerebrospinal fluid seen in aging mice and humans are associated with declining neurogenesis, neurodegenerative disease, and cognitive decline and may contribute to driving neovascularisation in AMD via interaction with CCR3 [1, 93, 123].”
From Fecal microbiota transfer between young and aged mice reverses hallmarks of the aging gut, eye, and brain (2022) · cites this paper as [1]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ranibizumab for Neovascular Age-Related Macular Degeneration
Rosenfeld, P. J., Brown, D. M., Heier, J. S., Boyer, D. S., Kaiser, P. K., Chung, C. Y., & Kim, R. Y. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054481 · Cited by 5,886
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., et al. (1996) · Nature · doi:10.1038/380435a0 · Cited by 4,162
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O’Shea, K. S., Powell-Braxton, L., Hillan, K. J., & Moore, M. W. (1996) · Nature · doi:10.1038/380439a0 · Cited by 3,661
Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration
Brown, D. M., Kaiser, P. K., Michels, M., Soubrane, G., Heier, J. S., Kim, R. Y., Sy, J. P., & Schneider, S. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062655 · Cited by 3,522
Pegaptanib for neovascular age-related macular degeneration
Gragoudas, E. S., Adamis, A. P., Cunningham, E. T., Feinsod, M., & Guyer, D. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042760 · Cited by 2,337
Genes Expressed in Human Tumor Endothelium
Croix, B. S., Rago, C., Velculescu, V. E., Traverso, G., Romans, K. E., Montgomery, E. A., Lal, A., Riggins, G. J., Lengauer, C., Vogelstein, B., et al. (2000) · Science · doi:10.1126/science.289.5482.1197 · Cited by 1,859
Rothenberg, M. E., & Hogan, S. P. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090720 · Cited by 1,356
Self-citationGene Expression Profiles in Normal and Cancer Cells
Zhang, L., Zhou, W., Velculescu, V. E., Kern, S. E., Hruban, R. H., Hamilton, S. R., Vogelstein, B., & Kinzler, K. W. (1997) · Science · doi:10.1126/science.276.5316.1268 · Cited by 1,186
Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies
Ambati, J., Ambati, B. K., Yoo, S. H., Ianchulev, S., & Adamis, A. P. (2003) · Survey of Ophthalmology · doi:10.1016/s0039-6257(03)00030-4 · Cited by 959
Self-citationSequence- and target-independent angiogenesis suppression by siRNA via TLR3
Kleinman, M. E., Yamada, K., Takeda, A., Chandrasekaran, V., Nozaki, M., Baffi, J., Albuquerque, R., Yamasaki, S., Itaya, M., Pan, Y., et al. (2008) · Nature · doi:10.1038/nature06765 · Cited by 939
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Mechanisms of Age-Related Macular Degeneration
Ambati, J., & Fowler, B. J. (2012) · Neuron · doi:10.1016/j.neuron.2012.06.018 · Cited by 1,062
Self-citationBachelerie, F., Ben‐Baruch, A., Burkhardt, A. M., Combadière, C., Farber, J. M., Graham, G. J., Horuk, R., Sparre‐Ulrich, A. H., Locati, M., Luster, A. D., et al. (2013) · Pharmacological Reviews · doi:10.1124/pr.113.007724 · Cited by 888
The Mouse Retina as an Angiogenesis Model
Stahl, A., Connor, K. M., Sapieha, P. S., Chen, J., Dennison, R. J., Krah, N. M., Seaward, M. R., Willett, K. L., Aderman, C. M., Guerin, K. I., et al. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-5176 · Cited by 638
DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration
Kaneko, H., Dridi, S., Tarallo, V., Gelfand, B. D., Fowler, B. J., Cho, W. G., Kleinman, M. E., Ponicsan, S. L., Hauswirth, W. W., Chiodo, V. A., et al. (2011) · Nature · doi:10.1038/nature09830 · Cited by 601
Self-citationDICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88
Tarallo, V., Hirano, Y., Gelfand, B. D., Dridi, S., Kerur, N., Kim, Y., Cho, W. G., Kaneko, H., Fowler, B. J., Bogdanovich, S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.036 · Cited by 592
Self-citationImmunology of age-related macular degeneration
Ambati, J., Atkinson, J. P., & Gelfand, B. D. (2013) · Nature reviews. Immunology · doi:10.1038/nri3459 · Cited by 606
Self-citationLRG1 promotes angiogenesis by modulating endothelial TGF-β signalling
Wang, X., Abraham, S., McKenzie, J. A. G., Jeffs, N. R., Swire, M., Tripathi, V. B., Luhmann, U. F. O., Lange, C., Zhai, Z., Arthur, H. M., et al. (2013) · Nature · doi:10.1038/nature12345 · Cited by 537
Parker, A., Romano, S., Ansorge, R., Aboelnour, A., Le Gall, G., Savva, G. M., Pontifex, M. G., Telatin, A., Baker, D., Jones, E., et al. (2022) · Microbiome · doi:10.1186/s40168-022-01243-w · Cited by 368
Animal models of choroidal and retinal neovascularization
Grossniklaus, H. E., Kang, S. J., & Berglin, L. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2010.05.003 · Cited by 350
Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma
Zhang, K., Zhang, L., & Weinreb, R. N. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3745 · Cited by 320
Systemic and Ocular Safety of Intravitreal Anti-VEGF Therapies for Ocular Neovascular Disease
Tolentino, M. J. (2011) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2010.08.006 · Cited by 303
Rangasamy, S., McGuire, P. G., Nitta, C. F., Monickaraj, F., Oruganti, S. R., & Das, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108508 · Cited by 245
Nucleoside reverse transcriptase inhibitors possess intrinsic anti-inflammatory activity
Fowler, B. J., Gelfand, B. D., Kim, Y., Kerur, N., Tarallo, V., Hirano, Y., Amarnath, S., Fowler, D. H., Radwan, M., Young, M. T., et al. (2014) · Science · doi:10.1126/science.1261754 · Cited by 225
Self-citationROCK-Isoform-Specific Polarization of Macrophages Associated with Age-Related Macular Degeneration
Zandi, S., Nakao, S., Chun, K., Fiorina, P., Sun, D., Arita, R., Zhao, M., Kim, E., Schueller, O. J. A., Campbell, A. S., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.01.050 · Cited by 199
Self-citationTargeted Radiotherapy with Gold Nanoparticles: Current Status and Future Perspectives
Ngwa, W. F., Kumar, R., Sridhar, S., Korideck, H., Zygmanski, P., Cormack, R. A., Berbeco, R. I., & Makrigiorgos, G. M. (2014) · Nanomedicine · doi:10.2217/nnm.14.55 · Cited by 173
Cytokine concentration in aqueous humour of eyes with exudative age‐related macular degeneration
Jonas, J. B., Tao, Y. K., Neumaier, M., & Findeisen, P. (2012) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.2012.02414.x · Cited by 159
Hajrasouliha, A. R., Jiang, G., Lu, Q., Lü, H., Kaplan, H. J., Zhang, H., & Shao, H. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.470765 · Cited by 147
Systemic and ocular fluid compounds as potential biomarkers in age-related macular degeneration
Kersten, E., Paun, C. C., Schellevis, R. L., Hoyng, C. B., Delcourt, C., Lengyel, I., Pető, T., Ueffing, M., Klaver, C. C. W., Dammeier, S., et al. (2017) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2017.05.003 · Cited by 146
CYTOKINE CONCENTRATION IN AQUEOUS HUMOR OF EYES WITH DIABETIC MACULAR EDEMA
Jonas, J. B., Jonas, R. A., Neumaier, M., & Findeisen, P. (2011) · Retina · doi:10.1097/iae.0b013e3182576d07 · Cited by 137
The Oral Iron Chelator Deferiprone Protects against Iron Overload–Induced Retinal Degeneration
Hadziahmetovic, M., Song, Y., Wolkow, N., Iacovelli, J., Grieco, S. F., Lee, J., Lyubarsky, A., Praticò, D., Connelly, J., Spino, M., et al. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-6207 · Cited by 119
Chemokine Receptor Antagonists
Pease, J. E., & Horuk, R. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300682j · Cited by 105
Song, D., Song, Y., Hadziahmetovic, M., Zhong, Y., & Dunaief, J. L. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.04.020 · Cited by 96
Inflammatory Mechanisms of Age-related Macular Degeneration
Knickelbein, J. E., Chan, C., Sen, H. N., Ferris, F. L., & Nussenblatt, R. B. (2015) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000073 · Cited by 98
Mo, F. M., Proia, A. D., Johnson, W. H., Cyr, D., & Lashkari, K. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-3910 · Cited by 97
Campa, C., Costagliola, C., Incorvaia, C., Sheridan, C., Semeraro, F., Nadai, K. D., Sebastiani, A., & Parmeggiani, F. (2010) · Mediators of Inflammation · doi:10.1155/2010/546826 · Cited by 97
Luo, L., Zhang, X., Hirano, Y., Tyagi, P., Barabás, P., Uehara, H., Miya, T. R., Singh, N., Archer, B. J., Qazi, Y., et al. (2013) · ACS Nano · doi:10.1021/nn305958y · Cited by 95
Self-citationSato, T., Takeuchi, M., Karasawa, Y., Enoki, T., & Ito, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-19594-6 · Cited by 90
“Chemokine receptors as therapeutic targets: Why aren’t there more drugs?”
Solari, R. C. E., Pease, J. E., & Begg, M. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.06.060 · Cited by 91
Hasegawa, E., Sonoda, K., Shichita, T., Morita, R., Sekiya, T., Kimura, A., Oshima, Y., Takeda, A., Yoshimura, T., Yoshida, S., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202495 · Cited by 87
Self-citationNarimatsu, T., Negishi, K., Miyake, S., Hirasawa, M., Osada, H., Kurihara, T., Tsubota, K., & Ozawa, Y. (2015) · Experimental Eye Research · doi:10.1016/j.exer.2015.01.003 · Cited by 84
Nanomedicine in Ophthalmology: The New Frontier
Zarbin, M. A., Montemagno, C. D., Leary, J. F., & Ritch, R. H. (2010) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2010.03.019 · Cited by 86
Genetics of Immunological and Inflammatory Components in Age-related Macular Degeneration
Tuo, J., Grob, S., Zhang, K., & Chan, C. (2012) · Ocular Immunology and Inflammation · doi:10.3109/09273948.2011.628432 · Cited by 80
Grozdanović, M. M., Laffey, K. G., Abdelkarim, H., Hitchinson, B., Harijith, A. K., Moon, H.-G., Park, G. Y., Rousslang, L. K., Masterson, J. C., Furuta, G. T., et al. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.05.003 · Cited by 77
Ge, Y. C., Zhang, A., Sun, R., Xu, J., Yin, T., He, H., Gou, J., Kong, J., Zhang, Y. X., & Tang, X. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2020.1735348 · Cited by 76
Yang, X. L., Liu, K. Y., Lin, F. J., Shi, H. M., & Ou, Z. L. (2017) · Oncology Reports · doi:10.3892/or.2017.5798 · Cited by 76
Neurovascular regulation in diabetic retinopathy and emerging therapies
Ji, L., Tian, H., Webster, K. A., & Li, W. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03893-9 · Cited by 76
Narimatsu, T., Ozawa, Y., Miyake, S., Kubota, S., Hirasawa, M., Nagai, N., Shimmura, S., & Tsubota, K. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-11572 · Cited by 73
Lichtlen, P., Lam, T. T., Nork, T. M., Streit, T., & Urech, D. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4890 · Cited by 75
Ha, Y., Liu, H., Xu, Z., Yokota, H., Narayanan, S. P., Lemtalsi, T., Smith, S. B., Caldwell, R. W., Caldwell, R. B., & Zhang, W. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.281 · Cited by 73
Age-Related Macular Degeneration: Insights into Inflammatory Genes
Cascella, R., Ragazzo, M., Strafella, C., Missiroli, F., Borgiani, P., Angelucci, F., Marsella, L., Cusumano, A., Novelli, G., Ricci, F., et al. (2014) · Journal of Ophthalmology · doi:10.1155/2014/582842 · Cited by 74
Regulation of signaling events involved in the pathophysiology of neovascular AMD.
Wang, H., & Hartnett, M. E. (2016) · Europe PMC (PubMed Central) · Cited by 72
Self-citationGregory, K. J., Zhao, B., Bielenberg, D. R., Dridi, S., Wu, J., Jiang, W., Huang, B., Pirie-Shepherd, S. R., & Fannon, M. W. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013428 · Cited by 66
Self-citationArginine metabolic control of airway inflammation
Asosingh, K., Lauruschkat, C. D., Alemagno, M., Frimel, M., Wanner, N., Weiss, K., Kessler, S. P., Meyers, D. A., Bennett, C. D., Xu, W., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.127801 · Cited by 67
Ocular Vascular Diseases: From Retinal Immune Privilege to Inflammation
Wang, X., Wang, T., Lam, E., Álvarez, D., & Sun, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512090 · Cited by 71
Current status of chemokine receptor inhibitors in development
Allegretti, M., Cesta, M. C., Garin, A., & Proudfoot, A. E. I. (2012) · Immunology Letters · doi:10.1016/j.imlet.2012.04.003 · Cited by 62
A Revised Hemodynamic Theory of Age-Related Macular Degeneration
Gelfand, B. D., & Ambati, J. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.06.009 · Cited by 65
Self-citationOxidative stress: The achilles' heel of neurodegenerative diseases of the retina
Cai, X. (2011) · Frontiers in bioscience · doi:10.2741/4033 · Cited by 63
Targeting chemokine receptors in allergic disease
Pease, J. E. (2011) · Biochemical Journal · doi:10.1042/bj20101132 · Cited by 66
Recent progress in the development of antagonists to the chemokine receptors CCR3 and CCR4
Pease, J. E., & Horuk, R. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.897324 · Cited by 59
Zhu, J. Z., Millard, C. J., Ludeman, J. P., Simpson, L. S., Clayton, D., Payne, R. J., Widlanski, T. S., & Stone, M. J. (2011) · Biochemistry · doi:10.1021/bi101240v · Cited by 59
Iannaccone, A., Giorgianni, F., New, D. D., Hollingsworth, T., Umfress, A. C., Alhatem, A., Neeli, I., Lenchik, N. I., Jennings, B., Calzada, J. I., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0145323 · Cited by 62
Anti-angiogenic Therapy for Retinal Disease
Paulus, Y. M., & Sodhi, A. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_78 · Cited by 60
Ye, F., Kaneko, H., Nagasaka, Y., Ijima, R., Nakamura, K., Nagaya, M., Takayama, K., Kajiyama, H., Senga, T., Tanaka, H., et al. (2015) · Scientific Reports · doi:10.1038/srep07705 · Cited by 55
Self-citationRole of microglia/macrophage polarisation in intraocular diseases (Review)
Li, H., Li, B., & Zheng, Y. (2024) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2024.5369 · Cited by 56
Jin, L., Liu, W., Tian, M., Jiang, X., Wang, H., Zhou, P., Ding, Z., Peng, Y., Dai, Z., Qiu, S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.14095 · Cited by 53
Balasubramanian, S., Venugopal, P., SundarRaj, S., Zakaria, Z., Majumdar, A. S., & Ta, M. (2011) · Cytotherapy · doi:10.3109/14653249.2011.605119 · Cited by 52
A novel antiangiogenic and vascular normalization therapy targeted against human CD160 receptor
Chabot, S., Jabrane‐Ferrat, N., Bigot, K., Tabiasco, J., Provost, A. C., Golzio, M., Noman, M. Z., Giustiniani, J., Bellard, E., Brayer, S., et al. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20100810 · Cited by 51
Huang, L., Li, Y., Xie, X., Zhang, J., Cheng, C., Yamashiro, K., Chen, L., Ma, X., Cheung, C. M. G., Wang, Y.-S., et al. (2015) · Nature Communications · doi:10.1038/ncomms7687 · Cited by 51
Drusen with Accompanying Fluid underneath the Sensory Retina
Sikorski, B. L., Sampson, D. M., Kałuzny, J. J., Szkulmowski, M., Kowalczyk, A. A., & Wojtkowski, M. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2010.04.017 · Cited by 52
Wang, H., Wittchen, E. S., Jiang, Y., Ambati, B. K., Grossniklaus, H. E., & Hartnett, M. E. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8230 · Cited by 51
Self-citationThe Antiangiogenic Effects of Integrin α5β1 Inhibitor (ATN-161) In Vitro and In Vivo
Wang, W., Wang, F., Lu, F., Xu, S., Hu, W., Huang, J., Gu, Q., & Sun, X. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-7097 · Cited by 51
Proteomic analysis of the aqueous humor in patients with wet age‐related macular degeneration
Yao, J., Liu, X., Yang, Q., Zhuang, M., Wang, F., Chen, X., Hang, H., Zhang, W., & Liu, Q. (2013) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201200012 · Cited by 49
Prolonged blockade of VEGF receptors does not damage retinal photoreceptors or ganglion cells
Miki, A., Miki, K., Ueno, S., Wersinger, D. M. B., Berlinicke, C., Shaw, G. C., Usui, S., Wang, Y., Zack, D. J., & Campochiaro, P. A. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22129 · Cited by 47
New Biomarker for Neovascular Age-Related Macular Degeneration: Eotaxin-2
Sharma, N. K., Prabhakar, S. K., Gupta, A., Singh, R., Gupta, P. K., Gupta, P., & Anand, A. (2012) · DNA and Cell Biology · doi:10.1089/dna.2012.1786 · Cited by 47
Hu, H., Liu, Y., Wang, L., & Li, W. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173716 · Cited by 47
Ahmad, I., Balasubramanian, S., Debbio, C. B. D., Parameswaran, S., Katz, A. R., Toris, C. B., & Fariss, R. N. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-6608 · Cited by 46
Aqueous humor cytokine profiling in patients with wet AMD.
Liu, F., Ding, X., Yu, Y., Li, J., Tang, M., Yuan, M., Hu, A., Zhan, Z., Li, Z., & Lü, L. (2016) · PubMed Central · Cited by 46
Leukotriene B4 promotes neovascularization and macrophage recruitment in murine wet-type AMD models
Sasaki, F., Koga, T., Ohba, M., Saeki, K., Okuno, T., Ishikawa, K., Nakama, T., Nakao, S., Yoshida, S., Ishibashi, T., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.96902 · Cited by 45
Self-citationIL-18 is not therapeutic for neovascular age-related macular degeneration
Hirano, Y., Yasuma, T. R., Mizutani, T., Fowler, B. J., Tarallo, V., Yasuma, R., Kim, Y., Bastos-Carvalho, A., Kerur, N., Gelfand, B. D., et al. (2014) · Nature Medicine · doi:10.1038/nm.3671 · Cited by 43
Self-citationBatabyal, S., Gajjeraman, S., Pradhan, S., Bhattacharya, S., Wright, W. W., & Mohanty, S. K. (2020) · Gene Therapy · doi:10.1038/s41434-020-00200-2 · Cited by 42
Angiostatic Effect of CXCR3 Expressed on Choroidal Neovascularization
Fujimura, S., Takahashi, H., Yuda, K., Ueta, T., Iriyama, A., Inoue, T., Kaburaki, T., Tamaki, Y., Matsushima, K., & Yanagi, Y. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8232 · Cited by 39
CC chemokine receptor-3 as new target for age-related macular degeneration
Sharma, N. K., Gupta, A., Prabhakar, S. K., Singh, R., Bhatt, A. K., & Anand, A. (2013) · Gene · doi:10.1016/j.gene.2013.03.052 · Cited by 40
Sakamoto, S., Takahashi, H., Tan, X., Inoue, Y., Nomura, Y., Arai, Y., Fujino, Y., Kawashima, H., & Yanagi, Y. (2017) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2017-310284 · Cited by 40
Dicing the Disease with Dicer: The Implications of Dicer Ribonuclease in Human Pathologies
Theotoki, E. I., Pantazopoulou, V. I., Georgiou, S., Kakoulidis, P., Filippa, V., Stravopodis, D. J., & Anastasiadou, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197223 · Cited by 41
Single-Molecule Tracking in Living Cells Using Single Quantum Dot Applications
Baba, K., & Nishida, K. (2012) · Theranostics · doi:10.7150/thno.3890 · Cited by 39
Restoring vision in mice with retinal degeneration using multicharacteristic opsin
Wright, W. W., Gajjeraman, S., Batabyal, S., Pradhan, S., Bhattacharya, S., Mahapatra, V., Tripathy, A., & Mohanty, S. K. (2017) · Neurophotonics · doi:10.1117/1.nph.4.4.041505 · Cited by 39
Loss of CD34 Expression in Aging Human Choriocapillaris Endothelial Cells
Sohn, E. H., Flamme‐Wiese, M. J., Whitmore, S. S., Wang, K., Tucker, B. A., & Mullins, R. F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086538 · Cited by 38
Hwang, Y., Chiang, P.-R., Hong, W.-H., Chiao, C., Chu, I., Hsiue, G., & Shen, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067495 · Cited by 38
Human IgG1 antibodies suppress angiogenesis in a target-independent manner
Bogdanovich, S., Kim, Y., Mizutani, T., Yasuma, R., Tudisco, L., Cicatiello, V., Bastos-Carvalho, A., Kerur, N., Hirano, Y., Baffi, J., et al. (2016) · Signal Transduction and Targeted Therapy · doi:10.1038/sigtrans.2015.1 · Cited by 37
Self-citationLiclican, E. L., Nguyen, V., Sullivan, A. B., & Gronert, K. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-5455 · Cited by 36
CCL11 promotes angiogenic activity by activating the PI3K/Akt pathway in HUVECs
Park, J. Y., Kang, Y. W., Choi, B. Y., Yang, Y. C., Cho, B. P., & Cho, W. G. (2017) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2017.1298132 · Cited by 36
Self-citationAssociations of IL-23 with Polypoidal Choroidal Vasculopathy
Sasaki, S.-I., Miyazaki, D., Miyake, K.-I., Terasaka, Y., Kaneda, S., Ikeda, Y., Funakoshi, T., Baba, T., Yamasaki, A., & Inoue, Y. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-7913 · Cited by 35
Sato, T., Takeuchi, M., Karasawa, Y., Takayama, K., & Enoki, T. (2019) · Scientific Reports · doi:10.1038/s41598-019-55191-x · Cited by 36
Rap1 GTPase Activation and Barrier Enhancement in RPE Inhibits Choroidal Neovascularization In Vivo
Wittchen, E. S., Nishimura, E., McCloskey, M., Wang, H., Quilliam, L. A., Chrzanowska‐Wodnicka, M., & Hartnett, M. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073070 · Cited by 34
Self-citationCCR3 and Choroidal Neovascularization
Li, Y., Huang, D., Xia, X., Wang, Z., Luo, L., & Wen, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017106 · Cited by 34
Nagineni, C. N., Kommineni, V. K., Ganjbaksh, N., Nagineni, K. K., Hooks, J. J., & Detrick, B. (2015) · Aging and Disease · doi:10.14336/ad.2015.0323 · Cited by 35
Suppression of Laser-Induced Choroidal Neovascularization by a CCR3 Antagonist
Mizutani, T., Ashikari, M., Tokoro, M., Nozaki, M., & Ogura, Y. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-9095 · Cited by 35
Self-citationPharmacological Potential of Small Molecules for Treating Corneal Neovascularization
Barry, Z., Park, B., & Corson, T. W. (2020) · Molecules · doi:10.3390/molecules25153468 · Cited by 36
IQGAP1 causes choroidal neovascularization by sustaining VEGFR2-mediated Rac1 activation
Wang, H., Ramshekar, A., Kunz, E., Sacks, D. B., & Hartnett, M. E. (2020) · Angiogenesis · doi:10.1007/s10456-020-09740-y · Cited by 33
Self-citationCCR3 Is Associated with the Death of a Photoreceptor Cell-line Induced by Light Exposure
Kuse, Y., Tsuruma, K., Kanno, Y., Shimazawa, M., & Hara, H. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00207 · Cited by 32
Ngwa, W. F., Makrigiorgos, G. M., & Berbeco, R. I. (2012) · Physics in Medicine and Biology · doi:10.1088/0031-9155/57/20/6371 · Cited by 32
The Small GTPase Rap1 Is a Novel Regulator of RPE Cell Barrier Function
Wittchen, E. S., & Hartnett, M. E. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-7295 · Cited by 31
Self-citationTakayama, K., Kaneko, H., Kataoka, K., Kimoto, R., Hwang, S.-J., Ye, F., Nagasaka, Y., Tsunekawa, T., Matsuura, T., Nonobe, N., et al. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/8694641 · Cited by 31
Self-citationCompartmentalized citrullination in Muller glial endfeet during retinal degeneration
Palko, S. I., Saba, N. J., Mullane, E. M., Nicholas, B. D., Nagasaka, Y., Ambati, J., Gelfand, B. D., Ishigami, A., Bargagna‐Mohan, P., & Mohan, R. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2121875119 · Cited by 31
Self-citationTransforming growth factor-β neutralizing antibodies inhibit subretinal fibrosis in a mouse model.
Zhang, H., & Liu, Z.-L. (2012) · Europe PMC (PubMed Central) · doi:10.3980/j.issn.2222-3959.2012.03.11 · Cited by 31
Secretogranin III: a diabetic retinopathy-selective angiogenic factor
Li, W., Webster, K. A., LeBlanc, M. E., & Tian, H. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2635-5 · Cited by 30
Hachana, S., Fontaine, O., Sapieha, P. S., Lesk, M. R., Couture, R., & Vaucher, E. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14962 · Cited by 32
Zhang, H., Yang, Y., Takeda, A., Yoshimura, T., Oshima, Y., Sonoda, K.-H., & Ishibashi, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068173 · Cited by 30
Self-citationAge-Related Macular Degeneration and the Other Double Helix The Cogan Lecture
Ambati, J. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-7328 · Cited by 30
Self-citationA pretargeted nanoparticle system for tumor celllabeling
Gunn, J., Park, S. I., Omid Veiseh, A., Press, O. W., & Zhang, M. (2010) · Molecular BioSystems · doi:10.1039/c005154c · Cited by 29
Metadata
- Authors
- Takeda, A., Baffi, J. Z., Kleinman, M. E., Cho, W. G., Nozaki, M., Yamada, K., Kaneko, H., Albuquerque, R. J. C., Dridi, S., Saito, K., Raisler, B. J., Budd, S. J., Geisen, P., Munitz, A., Ambati, B. K., Green, M. G., Ishibashi, T., Wright, J. D., Humbles, A. A., Gerard, C. J., Ogura, Y., Pan, Y., Smith, J. R., Grisanti, S., Hartnett, M. E., Rothenberg, M. E., & Ambati, J.
- Affiliations
- University of Kentucky (US)
- University of North Carolina at Chapel Hill (US)
- Cincinnati Children's Hospital Medical Center (US)
- University of Utah (US)
- Kyushu University (JP)
- Harvard University (US)
- Nagoya City University (JP)
- Oregon Health & Science University (US)
- University of Lübeck (DE)
- Corresponding author
- Ambati, Jayakrishna
- ORCID
- Venue
- Nature
- Published
- 2009-06-14
- Volume
- 460
- Issue
- 7252
- Pages
- 225-230
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC2712122
- OpenAlex
- W1978268544
- Cited by
- 263
- References
- 49
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 10 · 2023: 8 · 2022: 18 · 2021: 11 · 2020: 12 · 2019: 11 · 2018: 10 · 2017: 20 · 2016: 22 · 2015: 14 · 2014: 20 · 2013: 22 · 2012: 22
- FWCI
- 23.93
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- UNC Libraries
- Funders
- U.S. Department of Defense
- American Health Assistance Foundation
- International Retinal Research Foundation
- Research to Prevent Blindness
- Macula Vision Research Foundation
- E. Matilda Ziegler Foundation for the Blind
- National Institutes of Health
- National Heart, Lung, and Blood Institute
- National Eye Institute (R01EY017950, R01EY018836, R01EY015422, EY018836, R01EY018350, EY018350, EY 010572, EY017011, R01EY017182, EY017182, EY017950, EY015130, R01EY017011, P30EY010572, EY015422)
- National Institute of Allergy and Infectious Diseases (R01AI039759, R37AI045898, AI 45898, AI039759)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK076893, DK076893)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Keywords
- age-related macular degeneration, CCR3, choroidal neovascularization, eotaxin, eosinophils, mast cells, endothelial cell proliferation, anti-VEGF therapy, early diagnosis, quantum dot imaging, retinal neovascularization, blindness prevention, anti-angiogenic therapy
- MeSH terms
- Chemokine CCL26, Animals, Cell Movement, Cells, Cultured, Choroid, Disease Models, Animal, Humans, Inflammation, Leukocytes, Ligands, Macular Degeneration, Mice, Inbred C57BL, Retina, Chemokines, CC, Choroidal Neovascularization, Vascular Endothelial Growth Factor A, Endothelial Cells, Quantum Dots, Cell Proliferation, Mice, Receptors, CCR3, Chemokine CCL11, Chemokine CCL24
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review